These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1751588)
21. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern. Gordon B; Prentice E IRB; 1997; 19(2):8-11. PubMed ID: 11655323 [No Abstract] [Full Text] [Related]
22. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 2000 May; 11(8):1211-29. PubMed ID: 11660775 [No Abstract] [Full Text] [Related]
23. Institutional review boards and medical devices. Less JR; Alpert S; Nightingale SL JAMA; 1994 Sep; 272(12):968-9. PubMed ID: 8084066 [No Abstract] [Full Text] [Related]
24. FDA halts 27 gene therapy trials after illness: leukemia-like cases in 2 children in France prompt the action. Pollack A N Y Times Web; 2003 Jan; ():A1, A17. PubMed ID: 12647754 [No Abstract] [Full Text] [Related]
25. Trends in gene therapy regulation. Lecomte V; Taylor A Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906 [No Abstract] [Full Text] [Related]
26. Ban on medical experiments without consent is relaxed. Kolata G N Y Times Web; 1996 Nov; ():A1, C6. PubMed ID: 11647142 [No Abstract] [Full Text] [Related]
27. Proposed revisions to the Declaration of Helsinki--will they weaken the ethical principles underlying human research? Brennan TA N Engl J Med; 1999 Aug; 341(7):527-31. PubMed ID: 10441612 [No Abstract] [Full Text] [Related]
28. Gene therapy. Italians first to use stem cells. Abbott A Nature; 1992 Apr; 356(6369):465. PubMed ID: 1560817 [No Abstract] [Full Text] [Related]
29. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials. Annas GJ Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162 [No Abstract] [Full Text] [Related]
31. The changing clinical trials scene: the role of the IRB. Mitchell SC; Steingrub J IRB; 1988; 10(4):1-5. PubMed ID: 11650078 [No Abstract] [Full Text] [Related]
32. Monitoring of drug tests is faulted. Eichenwald K N Y Times Web; 1998 Jun; ():A14. PubMed ID: 11647564 [No Abstract] [Full Text] [Related]
33. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
34. Clinical considerations in the design of protocols for somatic gene therapy. Ledley FD Hum Gene Ther; 1991; 2(1):77-83. PubMed ID: 1863643 [TBL] [Abstract][Full Text] [Related]
35. Scientific and ethical considerations in human gene therapy. Lebo RV; Golbus MS Baillieres Clin Obstet Gynaecol; 1991 Sep; 5(3):697-713. PubMed ID: 1954734 [No Abstract] [Full Text] [Related]
36. Who's afraid of the human genome? Annas GJ Hastings Cent Rep; 1989; 19(4):19-21. PubMed ID: 2745060 [TBL] [Abstract][Full Text] [Related]
37. The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990. Anderson WF; Blaese RM; Culver K Hum Gene Ther; 1990; 1(3):331-62. PubMed ID: 11642817 [No Abstract] [Full Text] [Related]
38. Human experimentation: the review process in practice. Cowan DH Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165 [No Abstract] [Full Text] [Related]